- Type 1 diabetes may not be predominantly a 'disease of childhood' as more than 40 percent of type 1 diabetes cases have been reported to occur after the age of 30
- Many patients with type 1 diabetes after the age of 30 are thought to have type 2 diabetes at first, and so are not initially treated with insulin to control blood sugar levels
- In type 1 diabetes immune cells destroy the body's insulin producing beta cells and so patients need to be injected insulin to control their blood sugar levels, but with Type 2 diabetes little insulin may be produced so the treatment can be managed with diet and tablet therapy
- Distinguishing between type 1 or type 2 diabetes matters as it affects the treatment needed
Type 1 diabetes may not be disease of childhood as previously thought and is known to occur in adults. But type 1 cases are harder to recognize and correctly diagnose in adults because far more people develop type 2 diabetes in later life. The findings of this study are published in Lancet Diabetes & Endocrinology
Research by the University of Exeter Medical School using UK Biobank found that adults are as likely to develop type 1 diabetes as children, with more than 40 percent of type 1 diabetes cases occurring after the age of 30.
‘Among the adults with type 1 diabetes to have been misdiagnosed is Theresa May, the Prime Minister, who was initially told by doctors she had type 2 diabetes and given tablets which did not control her blood sugar
But many of those with type 1 diabetes after the age of 30 are thought to have type 2 diabetes at first, and not initially treated with insulin to control blood sugar levels. Previous published research by the University of Exeter Medical school found that, on average, it took a year for those with type 1 diabetes who had been misdiagnosed with type 2 to be put on insulin.
Among the adults with type 1 diabetes to have been misdiagnosed is Theresa May, the Prime Minister, who was initially told by doctors she had type 2 diabetes and given tablets which did not control her blood sugar.
Distinguishing between type 1 or type 2 diabetes matters as it affects the treatment needed. In type 1 diabetes immune cells destroy the body's insulin producing beta cells and people need to be injected insulin to control blood sugar levels. With Type 2 diabetes there is still insulin produced so it can be treated initially with diet and tablet therapy.
Type 1 diabetes has been typically viewed as a disease of childhood and adolescence as it accounts for more than 85 percent of diabetes in under 20s. But type 1 cases are harder to recognize and correctly diagnose in adults because far more people develop type 2 diabetes in later life. Type 2 accounts for 96% of diabetes cases between the ages of 31 and 60, the research shows.
A crucial clue to the possibility of adult-onset type 1 diabetes is the failure of tablets to control blood glucose. Adult-onset type 1 patients are also likely to be slim compared to type 2 patients who are often obese.
Exeter University's diabetes research team concluded that, although much less common than type 2 diabetes in adulthood, it is crucial that type 1 is diagnosed and treated correctly as it can be life threatening. They found that one in nine of the adult onset type 1 diabetes were admitted to hospital with diabetic ketoacidosis, a potentially fatal condition that develops when type 1 patients are not given insulin.
The study, Frequency and Phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank, published in the Lancet Diabetes & Endocrinology, is the first study to use a novel genetic analysis to identify type 1 diabetes in adults. This allows them to identify cases of type 1 diabetes not picked up by the patients' doctors.
Dr Richard Oram, a senior lecturer at the University of Exeter and Consultant Physician, said:
"Diabetes textbooks for doctors say that type 1 diabetes is a childhood illness. But our study shows that it is prevalent throughout life. The assumption among many doctors is that adults presenting with the symptoms of diabetes will have type 2 but this misconception can lead to misdiagnosis with potentially serious consequences. The Prime Minister is an example of someone who was misdiagnosed in this way at first. This study should raise awareness that type 1 diabetes occurs throughout adulthood and should be considered as a diagnosis."
Professor Andrew Hattersley, Professor of Molecular Medicine at the University of Exeter and Consultant Diabetologist at the Royal Devon and Exeter NHS Foundation Trust, said: "Type 1 diabetes is often mistaken for type 2 in adults. The diagnosis of type 1 diabetes in middle and old age is very difficult because almost all patients with diabetes at this age have type 2. Failure to recognise that the diabetes is type 1 rather than type 2 and give appropriate insulin treatment can be dangerous. Type 1 diabetes should be considered for any patient who is rapidly failing to respond to increasing doses of tablets especially if they are slim".
The study was funded by the Wellcome Trust and Diabetes UK. Dr Emily Burns, Head of Research Communications at Diabetes UK said: "Type 1 diabetes is much more common than type 2 diabetes in children and young adults. With increasing age, type 2 diabetes becomes more common, making type 1 diabetes less easy to identify. While more research is needed to understand the realities of misdiagnosis, we'd ask healthcare professionals to have this insight in mind: don't rule out type 1 diabetes after the age of 30."
Case study of Helen Philbin
Helen Philbin knew something was amiss with her diagnosis of type 2 diabetes. Slim and active, she felt her lifestyle could not have triggered the condition. More worryingly, the metformin she was prescribed was only worsening her symptoms. She continued to lose weight and had regular bouts of vomiting.
It was only when she took part in the Start Right study, led by the University of Exeter, that she discovered that she actually had type 1 diabetes and had been on the wrong medication for a year. She switched to insulin injections and soon the vomiting stopped and her weight began to stabilise.
Helen, a dental hygienist from Torquay, said: "Having the wrong diagnosis was extremely frustrating. I just knew it wasn't right. I'm an active person. I'm always running around with my two young kids and I walk the dog every day."
Helen had just turned 40 when she visited her GP after experiencing extreme thirst. Although she was underweight, her blood test strongly indicated diabetes. She was diagnosed with type 2 and prescribed metformin, and sent on a course to learn about lifestyle factors including a low-sugar diet.
"All the other people on the course were in their mid 60s and overweight," said Helen. "I was 5'10" and 9.5 stone. I stood out like a sore thumb. When I raised it with nurses or my GP, I was told that type 1 diabetes is always diagnosed in childhood, so I had to be type 2. I felt like I was banging my head against a wall."
Helen took the lifestyle advice seriously. She cut out carbs from her diet almost completely to get better blood sugar control, but she began vomiting up to four times a week. "It was horrible," she said. "Even a single piece of toast would send my blood sugar levels through the roof, and I was losing even more weight".
"I'm so pleased I was invited to take part in the trial and I got the right diagnosis. It's such a relief and it's made such a difference. I'm fine now. I haven't had a single episode of vomiting since switching to insulin, and I'm now gaining weight. My year on the wrong treatment was awful. I hope this research ensures more people can get the right treatment more swiftly."
- Nicholas J Thomas, MRCP, Samuel E Jones, PhD, Michael N Weedon, PhD, Beverley M Shields, PhD, Richard A Oram, PhD†, Prof Andrew T Hattersley, DM†,'Correspondence information about the author Prof Andrew T HattersleyEmail the author Prof Andrew T Hattersley.Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank, Lancet Diabetes & Endocrinology (2017). DOI: http://dx.doi.org/10.1016/S2213-8587(17)30362-5